Effect of subjective reasoning and neurocognition on medication adherence for persons with schizophrenia.
OBJECTIVE
This study investigated the relationship between patients' reasoning about medication adherence and neurocognitive and clinical indices for a treatment-compliant sample of Japanese patients with schizophrenia.


METHODS
Subjective reasoning about medication adherence was assessed by the Rating of Medication Influences (ROMI) scale. General intelligence, executive function, and verbal memory were assessed by the Wechsler Adult Intelligence Scale-Revised, Wisconsin Card Sorting Test, and Rey Auditory Verbal Learning Test, respectively.


RESULTS
Higher prevention scores were associated with lower executive functioning and older age. Influence of others was associated with years of education, medication dosage, and IQ, and medication affinity was associated with education.


CONCLUSIONS
These results suggest that executive functioning, education, and general IQ may all be important factors in individual motivation for medication adherence.
Maeda
Keiko
K
Department of Neuropsychiatry, Graduate School of Medicine, University of Tokyo, Bunkyo-ku, Japan.
Kasai
Kiyoto
K
Watanabe
Akira
A
Henomatsu
Katsuyo
K
Rogers
Mark A
MA
Kato
Nobumasa
N
D000328:Adult; D005260:Female; D006801:Humans; D007564:Japan; D008297:Male; D010349:Patient Compliance / Q000523:psychology*; D012559:Schizophrenia / Q000188:drug therapy*; D013850:Thinking